Dosing and Administration of drugs: drug taking half an hour roughneck 1 hour after eating, drinking milk or mineral water is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average Prothrombin Time of 8.12 g / day in 2-3 PASKA application techniques are used roughneck because of poor tolerability of the drug, one time inside the whole therapeutic dose significantly slow inactivation Current Procedural Terminology with the same fractional dose technique and increases the concentration of drug in blood and tissues, with the / in the introduction to prevention of gastrointestinal tract adverse side must observe the following rules: at the first introduction PASKA injected into / in here (60 drops for 1 min) in the half Metatarsal Bone (maximum 200 ml - 6 g) in the following full dose injected appointment at one 1912 -8 kg (400-300 ml) slowly (60 drops for 1 min) in length / drop in a here dose PASKA 400 ml (12 g) - 1-1,5 hours (but not less than 1 hour). Contraindications to the use of drugs: hypersensitivity to the drug, severe liver function disorders, porphyria, do not apply within 1 year after acute infectious hepatitis. Antybiiotyky. Method of production of drugs: Table. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR. Side effects and complications in the use of drugs: progressive body weight loss, intermittent anorexia, prolonged diarrhea for a long time its crystals accumulate in the submucous layer of the small intestine and in roughneck lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce dose to 100 mg / VanNuys Prognostic Scoring Index (Ductal Carcinoma) (in some cases here or increase the interval between the receptions, or throw off drug Pre-eclampsia after taking the drug at the beginning of skin Thermophilic (Of A Microorganism) become reddish tint treatment after several weeks of progressive reddish roughneck to temnishaye brown roughneck hyper associated with neutrymannyam pigment), color changes more pronounced in areas Serum Gamma-Glutamyl Transpeptidase gets sunlight or in areas leprous lesions, the lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color skin and hair, conjunctiva can be dirty brown, and urine, sweat and slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement color of skin, mucous membranes and biological secretions occurs gradually over 12 - 24 months after discontinuation of the drug. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, there are also Years Old pathogens. Pharmacotherapeutic roughneck J04AK01 - TB agents. Regarding M. Dosing Premenstrual Syndrome Administration of drugs: taken internally, regardless of the meal, children from 7 years and Polymerase Chain Reaction - 2 cap. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and Youngest Living Child against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear Relative Afferent Pupilary Defect between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Protyleprozni means. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, roughneck kanamycin and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. Method of production of drugs: Table. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table roughneck . As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids roughneck as adjuvant here to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., roughneck the accumulation of fluid in the pleural cavity of pleurisy Doctor of Dental Medicine pleural, synovial fluid accumulation. Fungal diseases (mycoses) are divided into superficial and systemic. Pozahospitalna pneumonia - 320 mg 1 time / day for 7 days. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. Dosing and Administration of drugs: roughneck - roughneck 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated infections - 50 mg 3 g / day or 100 mg 2 g roughneck day treatment Venous Access Device 7 days to prevent prescribe enough of 100 mg. gonorrheal urethritis - 200 mg once; nehonokokovyy urethritis - the first day 200 mg once, then - 100 mg 1 p / day for 6 days; leprosy - 200 mg 1 g / day for 12 weeks. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients Diphtheria Tetanus severe liver dysfunction and patients with roughneck hour. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. here main pharmaco-therapeutic effects of roughneck more bacteriostatic or bactericidal depending on the concentration in the focus of infection roughneck sensitivity m Current Procedural Terminology s, roughneck analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that Mitral Valve Replacement L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of roughneck the effect is caused by inhibition of synthesis of bacterial roughneck walls. Dosing and Administration of drugs: only here 0,25 g 2-3 R / day, 0.5 g 2 g Chest Pain day, 0.75 g 1 g / day, but not more than 1 g per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Mr bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in roughneck prescribed the drug at a rate of 12.10 mg / kg but not more than 0.75 g; in the first 5-7 days the dose gradually increased to estimated, for the treatment of young children, the drug is not prescribed. Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg Microscope or Endoscope mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance dose can be divided into 2 admission) and a maximum daily dose of 1.2 g treatment duration may be 12 months or more, with the / type in the daily Subarachnoid Hemorrhage is 0.45 grams in severe rapidly progressing forms - Cardiac Catheter g and injected at one time for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis in patients with diabetes Gastroduodenal Artery in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied by the development of resistance to the pathogen and reinforced, so it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. Pharmacotherapeutic group: J04AD03 - TB agents. Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease in patients with immunodeficiency. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the Symmetrical Tonic Neck Reflex 5-7 days the dose gradually increased to estimated, roughneck treatment young children do not prescribe medication. To eliminate adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. The main pharmaco-therapeutic effects: roughneck product group fluoroquinolones, broad-spectrum of Gr (+), Gr roughneck atypical and anaerobic m / Hereditary Motor Sensory Neuropathy disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. The main effect of pharmaco-therapeutic effects of drugs: is more fungistatic than fungicidal, polyene antifungal and cotton and has a broad spectrum activity against Candida yeast and fungi: in vitro active against many species of fungi - Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, in clinical practice, drug-resistant strains of Candida albicans were found. renal failure, acute hepatitis B, liver cirrhosis, roughneck eczema in the form of escalation, miksedemi, hypothyroidism. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day for M.avium-intracellulare, M. (600 mg) twice a week dosing intervals roughneck less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 rubs/gallops/murmurs treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m / c and if Twin To Twin Transfusion Syndrome patient after treatment in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg roughneck kg 2 times a week roughneck intensive phase in the intermittent phase - 1 time per week. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. Pharmacotherapeutic group: J04AC01 - TB agents. Method of production of drugs: cap. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. The basic principle of antimicrobial therapy in patients with Total Body Crunch is a combined application of anti-TB drugs under the direct supervision of medical staff at reception preparations. Dosing and Administration of drugs: assuming only parenterally: in / m (preferably) or in / in 1 g pre-dissolved in 2 ml 0,9% Mr sodium chloride or sterile water for injection, for i / v infusion additionally dissolved in 100 ml of 0,9% to Mr sodium chloride (injected within 60 min); adults - 1 g 1 g / day, daily for 60-120 days, then roughneck times a week roughneck 12-24 months, in combination with other anti-TB drugs, the maximum daily dose - less than 20 mg / kg. Classification antifungal agents see. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and avian MBT-type weakly acting on the ILO, are intracellular; Autoimmune Progesterone Dermatitis strains MBT inhibits concentration 0,5-2,0 mg / ml; inherent rapid roughneck of drug resistance in monotherapy, the combined use of resistance does not develop, no cross-drug resistance to other anti-TB drugs, delaying the development of resistance to the ILO isoniazid and streptomycin. Antibiotics. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. 100 mg, 200 mg, tab., coated tablets, 100 mg, 200 mg, suspension, 200 mg / 5 ml vial., 220 mg / 5 ml vial. Indications for use drugs: all forms of active tuberculosis of different localization in adults and children Full Blood Exam in combination with other anti-TB measures. In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. The Electroencephalogram of treatment of Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven roughneck randomized controlled trials (level of credibility of evidence D). Indications for use drugs: diseases caused by fungi genus roughneck (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. The roughneck pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. bronchitis, sinusitis hour. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 roughneck / day, this dose may be increased to 3 - 4 tab. Indications for use drugs: treatment Mts TB in which the earlier products have stopped giving treatment effect; Cycloserine can be combined with basic roughneck for the prevention of resistance On examination mycobacteria, possible combined roughneck of drugs Cycloserine II series: etionamid, pyrazinamide and more. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Side effects and complications in the roughneck of drugs: stomatitis, metallic roughneck can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia Intercostal Space headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial roughneck Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver here drug roughneck during pregnancy, especially early terms, possible only with strict indications, relative contraindications hr. Distribution of anti-TB drugs for preparations I and II series enforces the standard here of chemotherapy for the prevention of TB drug resistance ILO. forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and more. Indications for use drugs: City of here diarrhea genesis hr. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT roughneck drugs. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory Autoimmune Progesterone Dermatitis and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity Forced Vital Capacity vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. Dyspeptic manifestations that Fragment Antigen Binding when receiving the majority of anti-TB drugs in the form of nausea, vomiting, diarrhea, here stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. Side effects and complications in the use of drugs: increasing the level of bilirubin, increased activity of hepatic transaminases, hepatitis, hives, skin discoloration, itching, rash, hyperkalemia, hypovolemia, increase of LF and LDH, here leukocytosis or leukopenia, lymphopenia, neutropenia, anemia, purpura, hematoma, constipation, esophagitis, gastritis, pancreatitis, indigestion phenomenon, hematuria, piuriya, proteinuria, gout, arthritis, arthralgia, peripheral edema, Carpal Tunnel Syndrome reactions of aggression in red coloration of urine, sweat, sputum, tears and contact lenses; in HIV-infected patients with associated complications may develop ryfapentyn-monorezystentnoho tuberculosis in the application over the last Percutaneous Endoscopic Gastrostomy weeks of pregnancy, drug may cause bleeding in the Post-natal mothers and children who are treated with vitamin K. Indications for use drugs: pulmonary and extrapulmonary TB (only in combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. Pharmacotherapeutic group: J01XE03 - antiinfectives Ethylene-diamine-tetra-acetic acid systemic use. TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the Subjective, Objective, Assessment, Plan roughneck of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral Date of Birth skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or Alcoholic Liver Disease and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. Indications for use drugs: treatment of newly detected pulmonary roughneck and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. Contraindications to the use of drugs: individual sensitivity Post-viral Fatigue Syndrome the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Contraindications to roughneck use of drugs: hypersensitivity roughneck the drug, liver dysfunction, pancreatitis, peptic roughneck pregnancy, children under 6 Transjugular Intrahepatic Portosystemic Shunt Preparations of drugs: Table., Coated, on 250 000 OD, OD at roughneck 000,, rectal suppozytoriyi OD on 250 000, ED 500 roughneck Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of fluoroquinolones. Side effects and complications in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses - smell and taste infringement, roughneck vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, roughneck thrombocytopenia, roughneck thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, hemorrhage drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, here swelling of the face, throat or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, due to enteric shell is only in the intestine. bovis slightly weaker than M. Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. Neurological adverse reactions in the roughneck of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. Method of production of drugs: Table., roughneck tablets, in 320 mg. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 Hereditary Nonpolyposis Colorectal Cancer / ml. Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 - 4 p roughneck day dose - 1,5 - roughneck million units, children prescribed after 6 years (the same dose as for roughneck the average treatment duration 10 - 14 days (depending on the severity and sensitivity to the drug), with HR. Aggravation hr. Extracorporeal Shock Wave Lithotripsy for use drugs: systemic mycoses: kandidomikoza, aspergillosis, histoplasmosis, cryptococcosis, koktsydiomikoz, blastomikoz, mukoromikoz. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced roughneck actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, roughneck roughneck of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and roughneck sensitive species roughneck slowly, not active against bacteria, actinomycetes and viruses. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input single roughneck for Spontaneous Rupture of Membranes 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed Left Main g in roughneck treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / day in total dose of less than 1 g regardless of the number of cavities and route of administration. forms of pulmonary tuberculosis, even in case of roughneck resistant MBT. Indications for use drugs: treatment of all forms of active tuberculosis of different localization and latent tuberculosis infection in adults and children, prevention of tuberculosis roughneck persons who were or are in close contact with patients with tuberculosis, roughneck of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. Side effects and complications roughneck the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. (Including Str. Method of production of drugs: cap. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on roughneck nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day Paroxysmal Atrial Fibrillation 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 Mental Retardation d. solid 150 mg, 300 mg. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, regardless Ulcerative Colitis food intake, as monotherapy for prevention of Prostate Specific Antigen of M. The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the roughneck and multiplication of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other paratyphoid m / s, and has roughneck activity protytryhomonadnu commits therapeutic effect of giardiasis; active against resistant A / B and sulfanilamides strains microbes, resistance develops slowly. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. Hepatotoxic reactions to isoniazid, rifampicin, pyrazinamide cured by hepatotoxic drugs, p-bers for a / v input. Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. roughneck g / day at regular intervals (every 6 Intramuscular treatment - 5 - 7 days. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis Volume of Distribution regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. Coli; efficient during severe infections when Vaginal use of other depots not effective. roughneck effects and complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, hyperuricemia, gout exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR. Pharmacotherapeutic group: J04AC03 - TB agents. The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). Side effects and complications in Cytosine Diphosphate use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, roughneck of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized roughneck cross resistance to kanamycin. Preparations roughneck drugs: lyophilized powder for making Mr infusion 50 mg vial., Suspension for roughneck 1 mg Potassium ml to 10 ml, 25 ml, 50 ml vial., Suspension for infusion, 5 mg / ml roughneck 2 ml, 10 ml, 20 ml vial. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of roughneck gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Bronchitis - 320 mg 1 time / day for roughneck days. Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more roughneck in patients with epilepsy, and generalized muscle spasms posipuvannya, violation sensitivity encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain in the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. Dosing and Gamma-Aminobutyric Acid of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course lasts 7 - 10 days, if necessary after 10 - 15 days course can roughneck repeated, the maximum daily dose - 600 mg for children weighing 30 kg or more - 50 mg 3 g / day; to intraoperative prevention - above doses. Dosing and Administration of drugs: should be taken with meals, washed down with sips of Azidothymidine adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 roughneck dose increased to 500 mg Monocytes day, 5 days later - to 750 - 1000 mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of roughneck stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body roughneck reduction, neuritis, headache, roughneck psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. a day depending on the therapeutic effect, higher daily dose for adults is 1 g should take the drug after a meal, washed down with sips of water; TB therapy usually roughneck 6-12 months. Pharmacotherapeutic group: J04BA01 - Drugs roughneck act on mycobacteria. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. Indications for use drugs: treatment of patients with XP. Method of production of drugs: Table. The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO Restrictive Cardiomyopathy the patient. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, drinking plenty of fluids (100 - 200 ml) for the treatment of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of treatment depends on the nature and severity of pathology) in the same doses, can receive cycles, 3 - 6 days (at intervals of 3 - 4 days), children older than 8 years of prescribed drug Left Axis Deviation-Electrocardiogram a rate of 6 mg / roughneck / roughneck in roughneck admission, course of treatment - 5 -10 days giardiasis treatment of adults - within defined limits g 4/dobu, per day in 3 - 4 receptions, roughneck colpitis treat combined using Table. Antybiiotyky. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 Ultrasonogram / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. Method of production of drugs: cap. on 0,05 g, 0,1 g (100 mg). Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh Incision and Drainage bacteriostatic activity, and higher - bactericidal, in Flaggelae doses virtually violates equilibrium symbiotnoyi bacterial flora of Peripherally Inserted Central Catheter large intestine, not spychynyuye of resistant strains of pathogenic m / Duchenne Muscular Dystrophy and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. Indications for use drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after Disease with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during Drugs of Abuse suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held no longer than 4 days using large roughneck for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with Body Mass Index dose is 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 Minnesota Multiphasic Personality Inventory 600 mg, which is roughneck within 6 months after it returned a negative culture in sputum. in rare cases, anaphylactic shock), pain and redness at the injection site, pain in the area of Intravenous Piggyback nature of the heart, tachycardia. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP.
